Mechanism of IL-10-Induced T Cell Inactivation in Allergic Inflammation and Normal Response to Allergens
暂无分享,去创建一个
[1] C. Akdis,et al. A molecular basis for T cell suppression by IL‐10: CD28‐associated IL‐10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3‐kinase binding , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[2] C. Akdis,et al. IL‐10 directly acts on T cells by specifically altering the CD28 co‐stimulation pathway , 2000, European journal of immunology.
[3] C. Akdis,et al. IL‐10‐induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[4] C. Akdis,et al. Determinants and Mechanisms of Human Immune Responses to Bee Venom Phospholipase A2 , 1998, International Archives of Allergy and Immunology.
[5] C. Akdis,et al. Role of interleukin 10 in specific immunotherapy. , 1998, The Journal of clinical investigation.
[6] C. Akdis,et al. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. , 1998, The Journal of allergy and clinical immunology.
[7] C. Akdis,et al. Glucocorticoids inhibit human antigen‐specific and enhance total IgE and IgG4 production due to differential effects on T and B cells in vitro , 1997, European journal of immunology.
[8] M. Goldman,et al. IL-10: a potential therapy for allergic inflammation? , 1997, Immunology today.
[9] C. Akdis,et al. Induction and differential regulation of bee venom phospholipase A2-specific human IgE and IgG4 antibodies in vitro requires allergen-specific and nonspecific activation of T and B cells. , 1997, The Journal of allergy and clinical immunology.
[10] M. Jutel,et al. Influence of bee venom immunotherapy on degranulation and leukotriene generation in human blood basophils , 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[11] C. Akdis,et al. Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. , 1996, The Journal of clinical investigation.
[12] M. Jordana,et al. Interleukin (IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells. , 1996, The Journal of clinical investigation.
[13] H. Mosbech,et al. Position Paper: Immunotherapy with Hymenoptera venoms , 1993 .